Compare CCLD & CSBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CCLD | CSBR |
|---|---|---|
| Founded | 1999 | 1985 |
| Country | United States | United States |
| Employees | 3650 | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 98.6M | 81.0M |
| IPO Year | N/A | 2015 |
| Metric | CCLD | CSBR |
|---|---|---|
| Price | $2.63 | $5.17 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 316.0K | 8.3K |
| Earning Date | 05-07-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,900,000.00 |
| Revenue This Year | $11.49 | $4.84 |
| Revenue Next Year | $7.95 | $11.51 |
| P/E Ratio | $32.04 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.03 | $5.15 |
| 52 Week High | $4.01 | $8.74 |
| Indicator | CCLD | CSBR |
|---|---|---|
| Relative Strength Index (RSI) | 47.91 | 37.31 |
| Support Level | $2.12 | N/A |
| Resistance Level | $2.46 | $6.31 |
| Average True Range (ATR) | 0.13 | 0.29 |
| MACD | 0.02 | -0.06 |
| Stochastic Oscillator | 41.51 | 3.01 |
CareCloud Inc delivers flexible, tech-enabled solutions for healthcare providers of all sizes and multi-specialties across the U.S. It is a healthcare technology company offering cloud-based solutions that simplify clinical, administrative, and financial workflows for medical practices of all sizes. Its comprehensive suite includes Electronic Health Records (EHRs), Practice Management, Revenue Cycle Management (RCM), Medical Billing, Telehealth, and Patient Experience solutions. The group helps practices increase efficiency, improve patient care, and drive sustainable growth-all while ensuring HIPAA compliance and seamless integration. The operating segments of the group are Healthcare IT, which is the key revenue-generating segment, and Medical Practice Management.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.